HUNTSVILLE, Ala., Sept. 6 Open Biosystems, Inc., focusedon the commercialization of leading-edge life science research tools for drugdiscovery, announced today that three leading research institutions in NorthAmerica have adopted its Open Access RNAi Program. Baylor College ofMedicine, University of Minnesota and The Mayo Clinic have all recentlypurchased access to Open Biosystems shRNAmir and shRNA technologies for RNAiby joining the Open Access RNAi Program.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070423/CLM143LOGO )
Participation in the Open Access Programs allows all research laboratorieswithin an institution access to its choice of Open Biosystems' portfolio ofgenome-wide resources including RNAi. The Open Access Program, unique in thisfield, embodies Open Biosystems' commitment to expanding access to researchreagents for the life sciences community.
"The Open Access RNAi Program empowers investigators at Baylor College ofMedicine with leading edge RNAi resources to support studies to unravel thecomplexities of the genome," said Zhou (Sunny) Songyang, Associate Professor,Biochemistry and Molecular Biology at Baylor College of Medicine. "LentiviralshRNAmir technology from Open Biosystems will enable our researchers toharness the power of RNAi in assays and cell lines, previously limited byconventional siRNA technology, through lentiviral transduction and stablevector-based selection."
"Open Biosystems is very excited about the growing popularity of the OpenAccess Program for RNAi and other genomic resources. This program has fueledour mission to expand access to leading edge genomic resources within theresearch community," said Troy Moore, Chief Technical Officer of OpenBiosystems.
Open Biosystems' portfolio of RNAi resources include shRNAmir lentiviraland retroviral libraries targeting the entire human and mouse genomes, TheRNAi Consortium (TRC) human and mouse lentiviral shRNA libraries, lentiviralinducible shRNAmir library targeting the human genome as well as RNAicollections targeting Drosophila, C. elegans and Zebrafish.
About Open Access RNAi
The Open Biosystems Open Access RNAi Program gives entire academicsystems, including multiple campuses, access to the company's advanced shRNAlibraries, priority technical support, and continued access to all extensionsof existing libraries as well as library upgrades. In this manner, OpenBiosystems supports academic research without imposing heavy financial burdenson individual labs. The program is customizable and can be tailored to fitthe diverse needs of research institutions worldwide.
Complete details can be found at www.openbiosystems.com/OpenAccessRNAi
About Open Biosystems
Open Biosystems, Inc. develops, manufactures and markets genomic researchtools to scientists and researchers in corporate, academic and governmentlaboratories. These research tools provide investigators with standardizedhigh-quality genes, RNAi and antibodies for interrogating gene function inrelation to oncology, neuroscience and metabolic disorders. Founded in 2001,Open Biosystems is headquartered in Huntsville, Alabama. For more informationand details for ordering, please visit www.openbiosystems.com.
SOURCE Open Biosystems, Inc.